Search Results - "REBRIN, KERSTIN"

Refine Results
  1. 1

    Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes by STEIL, Garry M, REBRIN, Kerstin, DARWIN, Christine, HARIRI, Farzam, SAAD, Mohammed F

    Published in Diabetes (New York, N.Y.) (01-12-2006)
    “…Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes Garry M. Steil 1 , Kerstin Rebrin 1 , Christine Darwin 2 , Farzam Hariri 2 and…”
    Get full text
    Journal Article
  2. 2

    Use of Subcutaneous Interstitial Fluid Glucose to Estimate Blood Glucose: Revisiting Delay and Sensor Offset by Rebrin, Kerstin, Sheppard, Norman F., Steil, Garry M.

    Published in Journal of diabetes science and technology (01-09-2010)
    “…Background: Estimates for delays in the interstitial fluid (ISF) glucose response to changes in blood glucose (BG) differ substantially among research groups…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring by Rebrin, K, Steil, G M, van Antwerp, W P, Mastrototaro, J J

    Published in The American journal of physiology (01-09-1999)
    “…The present study investigated the relationship between blood and subcutaneous interstitial fluid (ISF) glucose by employing an amperometric glucose sensor…”
    Get full text
    Journal Article
  5. 5

    Evaluation of the Effect of Gain on the Meal Response of an Automated Closed-Loop Insulin Delivery System by Panteleon, Antonios E, Loutseiko, Mikhail, Steil, Garry M, Rebrin, Kerstin

    Published in Diabetes (New York, N.Y.) (01-07-2006)
    “…Evaluation of the Effect of Gain on the Meal Response of an Automated Closed-Loop Insulin Delivery System Antonios E. Panteleon , Mikhail Loutseiko , Garry M…”
    Get full text
    Journal Article
  6. 6

    Can interstitial glucose assessment replace blood glucose measurements? by Rebrin, K, Steil, G M

    “…Current treatment regiments for individuals depending on exogenous insulin are based on measurements of blood glucose obtained through painful finger sticks…”
    Get more information
    Journal Article
  7. 7

    Evaluation of Insulin Sensitivity and β-Cell Function Indexes Obtained From Minimal Model Analysis of a Meal Tolerance Test by STEIL, Garry M, HWU, Chi-Min, JANOWSKI, Robert, HARIRI, Farzam, JINAGOUDA, Sujata, DARWIN, Christine, TADROS, Sameh, REBRIN, Kerstin, SAAD, Mohammed F

    Published in Diabetes (New York, N.Y.) (01-05-2004)
    “…Evaluation of Insulin Sensitivity and β-Cell Function Indexes Obtained From Minimal Model Analysis of a Meal Tolerance Test Garry M. Steil 1 , Chi-min Hwu 2 ,…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The role of the independent variable to glucose sensor calibration by Panteleon, Antonios E, Rebrin, Kerstin, Steil, Garry M

    “…In vivo subcutaneous glucose sensor accuracy depends on the calibration method. Sensor accuracy was assessed during standard oral glucose tolerance tests in…”
    Get more information
    Journal Article
  10. 10

    Continuous monitoring of interstitial tissue oxygen using subcutaneous oxygen microsensors: In vivo characterization in healthy volunteers by Kanick, Stephen C., Schneider, Peter A., Klitzman, Bruce, Wisniewski, Natalie A., Rebrin, Kerstin

    Published in Microvascular research (01-07-2019)
    “…Measurements of regional tissue oxygen serve as a proxy to monitor local perfusion and have the potential to guide therapeutic decisions in multiple clinical…”
    Get full text
    Journal Article
  11. 11

    Abstract 303: Monitoring Tissue Oxygen Dynamics With A Novel Implantable Hydrogel Sensor In Patients With Pad by Iannuzzi, James C, Conte, Michael S, Rebrin, Kerstin, Lozano, Monica M, Menke, Laura, Cheng, David, Smith, Eric, Schneider, Peter, Vartanian, Shant

    “…ObjectiveTissue perfusion measurement remains a fundamental challenge in management of peripheral arterial disease (PAD) patients. Better measurement of…”
    Get full text
    Journal Article
  12. 12

    72-LB: Clinical Evaluation of a Long-Term Optical Continuous Glucose Monitoring (CGM) System: Lumee Glucose by TRAN, KHANH Q., NGUYEN, CHLOE, NGUYEN, HIEP T., GAMSEY, SOYA J., LEPAK, CLAYTON G., REBRIN, KERSTIN

    Published in Diabetes (New York, N.Y.) (01-06-2021)
    “…Profusa is developing a CGM System which tracks glucose concentrations in interstitial fluid for several months. It consists of a small hydrogel sensor (2.5 x…”
    Get full text
    Journal Article
  13. 13

    681-P: Evaluation of Data Processing Performance for Subcutaneous Glucose Monitoring with an Optical Investigational Device by MADER, JULIA K., SIEGL, REBECCA, REINHARD, ANNA K., KOPANZ, JULIA, SIMIC, AMRA, HARTMANN, MATTHIAS, GAMSEY, SOYA J., BANERJEE, SAYANTI, KAMECKE, ULRIKE, REBRIN, KERSTIN

    Published in Diabetes (New York, N.Y.) (01-06-2022)
    “…Background and Aims: Lumee Glucose is a small soft glucose-sensitive hydrogel (5.0 x 0.75 x 0.65mm hydrated) currently in clinical development and intended for…”
    Get full text
    Journal Article
  14. 14

    Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion by McVey, Elaine, Hirsch, Laurence, Sutter, Diane E, Kapitza, Christoph, Dellweg, Sibylle, Clair, Janina, Rebrin, Kerstin, Judge, Kevin, Pettis, Ronald J

    Published in Journal of diabetes science and technology (01-07-2012)
    “…Intradermal (ID) delivery has been shown to accelerate insulin pharmacokinetics (PK). We compared the PK and pharmacodynamic (PD) effects of insulin lispro…”
    Get full text
    Journal Article
  15. 15

    Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear by Rini, Christopher James, McVey, Elaine, Sutter, Diane, Keith, Stephen, Kurth, Heinz-Joerg, Nosek, Leszek, Kapitza, Christoph, Rebrin, Kerstin, Hirsch, Laurence, Pettis, Ronald J.

    Published in Drug delivery and translational research (01-08-2015)
    “…Rapid uptake previously demonstrated by intradermal (ID) drug administration indicates compound delivery within the dermis may have clinical and…”
    Get full text
    Journal Article
  16. 16

    Metabolic modelling and the closed-loop insulin delivery problem by Steil, Garry, Rebrin, Kerstin, Mastrototaro, John J.

    Published in Diabetes research and clinical practice (01-12-2006)
    “…The approach used by Medtronic MiniMed to close the insulin delivery loop using the subcutaneous site for both glucose sensing and insulin delivery relies on…”
    Get full text
    Journal Article
  17. 17

    Closed-loop insulin delivery - what lies between where we are and where we are going? by Steil, Garry M, Rebrin, Kerstin

    Published in Expert opinion on drug delivery (01-03-2005)
    “…Closed-loop insulin delivery in individuals with diabetes can potentially lead to near-normal glucose profiles. To this end, existing subcutaneous glucose…”
    Get more information
    Journal Article
  18. 18

    Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor by Steil, Garry M, Rebrin, Kerstin, Mastrototaro, John, Bernaba, Basem, Saad, Mohammed F

    “…Continuous glucose monitoring has the potential to improve glucose management and reduce the risk of hypoglycemia in individuals with diabetes. Accurate…”
    Get more information
    Journal Article
  19. 19

    Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin by REBRIN, K, STEIL, G. M, GETTY, L, BERGMAN, R. N

    Published in Diabetes (New York, N.Y.) (01-09-1995)
    “…Overproduction of glucose by the liver in the face of insulin resistance is a primary cause of hyperglycemia in non-insulin-dependent diabetes mellitus…”
    Get full text
    Journal Article
  20. 20

    Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis by Steil, Garry M, Rebrin, Kerstin, Janowski, Robert, Darwin, Christine, Saad, Mohammed F

    “…Glucose sensing and insulin delivery technology can potentially be linked to form a closed-loop insulin delivery system. Ideally, such a system would establish…”
    Get more information
    Journal Article